Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SOCS highlighted at a recent meeting as future drug design targets

Sep. 6, 2006

Promising efficacy for a novel ragweed immunotherapy vaccine

Sep. 4, 2006

Pluristem awarded Israeli grant for stem cell product PLX-1

Sep. 4, 2006

ACE-393 vaccine against C. jejuni begins phase I

Sep. 4, 2006

Recent Synta patent describes novel immunosuppressant agents

Aug. 31, 2006

Rapamycin shows efficacy against Listeria monocytogenes infection in mice

Aug. 30, 2006

Sinovac Biotech reports preliminary phase I trial of pandemic influenza vaccine

Aug. 30, 2006

ImmunoVaccine Technologies to use PADRE for vaccines

Aug. 28, 2006

Anthrax vaccine rPA-102 well tolerated, induces antibody responses in humans

Aug. 24, 2006

TAFA-93 shows promise in phase I studies

Aug. 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...